Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Revive Therapeutics Ltd.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by larooon Apr 25, 2017 8:41pm
101 Views
Post# 26165894

RE:RE:RE:RE:RE:RE:RE:InMed waaaaay oversold.. Back in at .65 :)

RE:RE:RE:RE:RE:RE:RE:InMed waaaaay oversold.. Back in at .65 :)
KimKWest wrote: Thank you hun. I appreciate it. And I do know about Inmed. But please don't try to start a fight with me for no reason. I was just asking questions. Isn't this what the board is for? Get grip boo.

Anyways lm beautiful and smart. That's why I'm investing in RVV. Too bad people handle my sassiness. Off for the night. Love you all xoxo GLTA  




On a number of levels this may be the worst post I've ever seen on any stock message board ever. I get nauseous imagining the creature pounding the keys on the other end of this post. A good lesson on why investors should put ZERO credence in the Stockhouse bullboard.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities